About Bioline  All Journals  Testimonials  Membership  News  Donations

Australasian Biotechnology (backfiles)
ISSN: 1036-7128
Vol. 8, No. 2, 1998
Bioline Code: au98014
Full paper language: English
Document type: Research Article
Document available free of charge

Australasian Biotechnology (backfiles), Vol. 8, No. 2, 1998

 en Biopartnering - An illustration


Australasian Biotechnology,
Volume 8 Number 2, March/April 1998, pp. 77-80


Biopartnering - An illustration

Mitzi Gilligan, Minter Ellison

Code Number:AU98014
Sizes of Files:
Text: 17K
Graphics: No associated graphics files

The aim of this article is to provide a general outline of some of the commercial and legal issues which must be considered when negotiating a biopartnering deal. I have chosen to focus on a biopartnering deal between a biotechnology company and a larger (and possibly international) pharmaceutical company. The article therefore mainly considers the issues surrounding biopartnering in human therapeutics where both parties are corporate entities. Whilst some different factors will apply in relation to other types of biopartnering, for example, where one of the parties is an academic or charitable research organisation, or the field is not human therapeutics, many of the general issues will remain the same. In order to make this article more digestible, I have chosen the format of an imaginary letter to me by a fictional client which I call "Cureall Biotech". The letter requests some advice on a proposed biopartnering deal and my response outlines the issues to be considered.

Copyright 1998 Australian Biotechnology Association Ltd.


Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2020, Site last up-dated on 28-Nov-2020.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil